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accurate assessment of disease activity and extent in IBD seems to be of paramount importance for optimized medical therapy, scoring systems are required that give com parable results through different studies, therefore enabling appropriate therapeutic decisions to be made. The UCCIS meets these criteria, as agreement for most of the parameters in this study were good to excellent among a wide variety of inves tigators. Another strength of the study is that all different segments of the colon were scored; ulcerative colitis can have a patchy appearance on endoscopy, particu larly when the patient is receiving treat ment. As also mentioned by the authors, the definition of mucosal healing that was recently proposed by the International Organisation for the Study of Inflammatory Bowel Disease comprises of the absence of friability, blood, erosions and ulcers in all segments of the bowel. 8 The UCCIS, which describes mucosal lesions from the entire colon, might therefore become increasingly important for future studies on mucosal healing. As advanced endoscopic imaging modalities gain increasing importance in the evaluation of IBD, one advantage of the study is also the use of highdefinition endoscopes. Most of the previous studies on endoscopic scoring systems only use stand ard or highresolution endoscopic imaging. 9 Lastly, the UCCIS was also correlated with clinical indices of disease activity and laboratory data.
Potential limitations of the study have to be addressed. For instance, the study was performed at just one centre and only expert gastroenterologists, experienced in the diagnosis and treatment of IBD, scored the videos for the UCCIS. Future research should now focus on the ques tion of whether nonexperienced gastro enterologists or even gastroenterology fellows are able to gain similar results. Moreover, only three of four parameters of the UCCIS showed at least good inter observer agreement; bleeding/friability, in particular in the sigmoid and descending colon, did not have good inter observer agreement. One recent study on the develop ment of the ulcerative colitis endo scopic index of severity also described a weakened κ value of only 0.30 for friabil ity. 10 This finding might be attributable to the ambiguous definition of friability or to the lack of understanding of this abnormality. Another explanation might be that all video clips were prepared on the withdrawal phase of the endoscopic examination. As advancement of the endo scope to the caecum can cause mucosal fri ability and slight bleeding, and these lesions mostly occur according to the shearing force in the sigmoid and descending colon, the investigators might judge differently on the cause of the friability (disease versus shearing force). Whether the authors could improve the interobserver agree ment for bleeding/friability if they instead analysed the left colon during advancement of the endoscope to the caecum would be interesting to determine. In addition, only outpatients were recruited to the study and thus the responsiveness of the UCCIS in hospitalized patients with severe ulcerative colitis is unclear. Additional studies should now also focus on this special cohort of patients.
In summary, the study by Samuel and coworkers 2 approved the UCCIS as a valid and easy tool for endoscopic assessment of mucosal healing in patients with ulcerative colitis. Future research should now focus on larger multicentre studies that also include nonexperts in the management of IBD to validate the UCCIS for its usefulness in research and clinical decisionmaking. 
COLORECTAL CANCER
CRC-all about microbial products and barrier function?
Christian Jobin
Novel findings draw attention to the adverse effect that neoplastic transformation of epithelial cells has on intestinal barrier function and cancer progression. An impaired intestinal barrier facilitated the translocation of microbial products, which promoted cytokine production and subsequent tumour progression in mice. The inflammatory microenvironment sur rounding tumours has long been identified as a powerful modifier of cancer develop ment. A new study greatly contributes to our understanding of the intricate inter play between the intestinal milieu, host inflammatory responses and colorectal cancer (CRC). 1 Grivennikov and colleagues 1 demon strate in mice that defective intesti nal barrier function at tumour sites facili tates the translocation of bacterial products, leading to activation of the myeloidcell derived Il23-Il17 cytokine network and promotion of tumour growth.
From the mouth to the rectum, the gastro intestinal tract is delineated by a single layer of epithelial cells that main tains intestinal homeostasis by two main mechanisms: by absorbing, secreting and transporting water, nutrients and macro molecules; and by forming a physical separation between the mucosal immune system and the luminal compartment, which contains a complex microbiota esti mated at a total of 10 14 microorganisms. Inappropriate translocation of bacteria and bacterialderived products (for example, lipopolysaccharide [LPS], nucleic acids and flagellin) into the mucosal compartment could have pathological consequences for the host. In an elegant study by Grivennikov and coworkers, 1 we learn that defective barrier function is observed early in neo plastic progression, a phenomenon leading to increased LPS translocation into the mucosal compartment and increased pro duction of myeloidcellderived Il23p19 and downstream effector cytokines Il6 and Il17a. This bacteriainduced local mucosal inflammation favours tumour growth and cancer progression in a mouse model of CRC (Figure 1 ).
Grivennikov and colleagues 1 investigated the interplay between intestinal barrier function, cytokine production and tumour progression. Using a spontaneous model of CRC in which the adenomatous poly posis coli (Apc) gene is selectively deleted by a Cdx2driven cre recombinase (CPC APC mice), the authors observed abun dant production of Il23p19 and Il17a in tumour sites compared with adjacent normal 'healthy' tissue. A similar increase of IL23p19 and IL-17a mRNA was noted in human CRC tumours compared with control tissue samples. Genetic ablation of Il-23p19 strongly attenuated tumour development in CPCAPC mice, which correlated with decreased expression of Il-17a. The authors next investigated the role of innate immune signalling proteins in driving this unique inflammatory environ ment. Using bone marrow from mice with defective innate immune signalling-
Myd88
-/-, Tlr2 -/-, Tlr4 -/-and Tlr9 -/-micethey demonstrated that CPCAPC mice that had immune systems reconstituted with this bone marrow displayed reduced Il-23p19 mRNA production. Interestingly, epithelialspecific Myd88 deletion led to compromised barrier function and increased mucosal bacteria adherence, showing the complexity of MyD88 signal ling in intestinal homeostasis.
2 CPCAPC mice transplanted with bone marrow from Myd88 -/-mice exhibited a strong reduction in tumour development, which correlated with decreased Il17a colonic tissue produc tion. Antibioticmediated bacterial deple tion markedly attenuated Il-23p19-Il-17a mRNA levels and CRC development in CPCAPC mice, thus the authors concluded that microbial products must be responsible for this pathology.
A key function of the epithelial barrier is to isolate the host from the potential harmful microbial population inhabiting the intestinal lumen. From Grivennikov's data, it seems that this task is not ade quately performed by the epithelium of CPCAPC mice. To characterize barrier function in CPCAPC mice, permeability assays were performed using fluorescein isothyocyanate (FITC)labelled dextran and Alexa488labelled LPS. 1 The research ers observed an increased translocation of both FITCdextran and Alexa488labelled LPS in tumour lesions of CPCAPC mice, but not in normal 'healthy' adjacent tissues. Furthermore, they observed a reduction in the number of goblet cells and reduced levels of the barrier protecting mucin2 protein in tumour lesions. At the molecular cellular level, the authors noticed decreased expression of junctional adhesion mol ecule A and mislocalization of claudin4 in epithelial cells from tumour lesions compared with normal tissues. Finally, using a tamoxifen inducible gene dele tion system, they demonstrated that Apc loss parallels epithelial cell transformation, decreased mucin production and increased Il-23 expression, suggesting that early neo plastic changes set in motion a break down of barrier function and dysregulated intestinal immune responses.
This study by Grivennikov and col leagues 1 brings into light the intricate inter play between the intestinal barrier, luminal microbial products and mucosal immune compartment in the progression of CRC. Although illuminating, the study raises a number of intriguing questions that must be addressed before this new paradigm can be fully understood. The most press ing question relates to the luminal bacte rial entities or products driving immune cell activation and cancer progression. As alluded to by Grivennikov et al., 1 Tolllike receptor 4 (Tlr4) (and presumably LPS) acts 
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as tumour promoter, 3 whereas the innate sensor nucleotidebinding oligomeriza tion domain containing protein 1 (Nod1) confers protection in mice against the same pathology. 4 As Tlr4 and Nod1 detect differ ent microbial products (LPS and peptido glycan, respectively), it will be important to define the nature of the microbial antigen that influences CRC development in the CPCAPC model, and verify whether the findings are reproduced in other experi mental models of CRC. Genetic ablation of Nod1, Nod2 or other Nodlike receptors will help define the differential contribution of bacterial products in CRC. Nod2 is of particular interest as this innate sensor has been linked to CRC development by find ings from a metaanalysis. 5 Consequently, the relevance of the study to human pathology would need to be confirmed.
Another important aspect requiring further investigation is the relationship between microbial composition and CRC susceptibility. Probably, the defective barrier function observed in CPCAPC mice would not only permit enhanced translocation of bacteria and bacterial products, but also increased colonization of adherent bacte ria at neoplastic sites. Recent studies have shown differences in microbial community composition and richness in healthy rectal tissue from patients with adenomas versus healthy individuals. [6] [7] [8] [9] Therefore, it will be important to longitudinally examine the microbial community of normal tissue and tumour lesions of CPCAPC mice, and then apply gnotobiotic technology to determine cause-effect relationships between dys biotic microbiota and the development of CRC.
The findings by Grivennikov and col leagues 1 imply that defective barrier func tion is an early biological event in colorectal tumorigenesis and represents a crucial step for activation of underlining immune cells by microbial products. It will be necessary to translate these findings to humans and to determine whether early neoplastic changes are accompanied by increased permeability defects and bacterial translocation. Of note, patients with IBD-a population at high risk of developing CRC-exhibit increased intestinal permeability that precedes clini cal inflammatory symptoms. 10 Improving intestinal barrier function is already a pri ority for clinicians managing patients with IBD, and the work of Grivennikov et al. 1 demonstrates that targeting intestinal per meability should be evaluated as a potential therapeutic avenue for individuals at high risk of developing CRC. 
